| 1 |
34439151 | MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms. | 2021 Aug 8 |
2 |
| 2 |
28867193 | TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ. | 2017 Nov 4 |
3 |
| 3 |
26346170 | 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules. | 2016 Feb |
6 |
| 4 |
23339090 | Role of 14-3-3σ in resistance to cisplatin in non-small cell lung cancer cells. | 2013 Jan |
10 |
| 5 |
24185104 | 14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells. | 2013 Nov |
7 |
| 6 |
19528459 | 14-3-3sigma-dependent resistance to cisplatin. | 2009 Jun |
3 |
| 7 |
17163167 | Methylation patterns and chemosensitivity in NSCLC. | 2006 |
1 |
| 8 |
16361617 | 14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group. | 2005 Dec 20 |
2 |
| 9 |
15467455 | RACK1 and stratifin target DeltaNp63alpha for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage. | 2004 Oct |
2 |